A Phase III Prospective Random Assignment Trial of Regional and Systemic Chemotherapy With or Without Initial Isolated Hepatic Perfusion for Patients With Metastatic Unresectable Colorectal Cancers of the Liver.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Floxuridine; Fluorouracil; Folinic acid; Irinotecan; Melphalan
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 08 Mar 2012 Biomarkers information updated
- 07 Mar 2012 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 07 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.